We are live on
!
Find out more
ICP
Indus Capital Partners Portfolio holdings
AUM
$39.7M
1-Year Est. Return
53.95%
This Fund
S&P 500
This Quarter
Est. Return
-9.84%
1 Year Est. Return
+53.95%
3 Year Est. Return
+114.84%
5 Year Est. Return
+42.53%
10 Year Est. Return
+777%
AUM
$246M
AUM Growth
-$177M
(-42%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-53.3%
Top 10 Holdings %
Top 10 Hldgs %
80.34%
Holding
40
New
6
Increased
6
Reduced
15
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GrafTech
EAF
|
+$11M |
| 2 |
ACM Research
ACMR
|
+$7.75M |
| 3 |
Yum China
YUMC
|
+$3.89M |
| 4 |
TSMC
TSM
|
+$3.89M |
| 5 |
Cemex
CX
|
+$3.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONC
BeOne Medicines Ltd
ONC
|
+$28.8M |
| 2 |
HDFC Bank
HDB
|
+$20.8M |
| 3 |
Baidu
BIDU
|
+$11.3M |
| 4 |
argenx
ARGX
|
+$10.3M |
| 5 |
RLX Technology
RLX
|
+$9.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 36.48% |
| 2 | Technology | 24.97% |
| 3 | Consumer Discretionary | 11.12% |
| 4 | Real Estate | 7.05% |
| 5 | Healthcare | 6.95% |
Similar funds
CF
8GI
EV
TCM
DDSF
IVAI
SPIG
CIC
Indus Capital Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Indus Capital Partners held 40 positions worth $246M, down 42% from $423M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Indus Capital Partners withdrew a net $131M in Q1 2022, closing 13 positions and reducing 15 holdings. Its most notable exit was BeOne Medicines Ltd, an estimated $28.8M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 36% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Indus Capital Partners opened a new position in Yum China worth $3.43M.
- Indus Capital Partners's largest Q1 2022 buy was Yum China: 82,605 shares worth $3.43M.
- Indus Capital Partners added most to GrafTech in Q1 2022, an estimated $11M increase.
- Indus Capital Partners's biggest Q1 2022 reduction was HDFC Bank, cutting an estimated $20.8M.
- Indus Capital Partners fully exited BeOne Medicines Ltd in Q1 2022, selling an estimated $28.8M.
- Indus Capital Partners's ten largest holdings make up 80% of its $246M portfolio in Q1 2022.
- Indus Capital Partners opened 6 new positions and closed 13 in Q1 2022.
- Indus Capital Partners's portfolio value fell 42% quarter-over-quarter to $246M.
Based on Indus Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.